highperformr logo

Avanthika Chaithanya

Pediatric Resident Physician, Icahn School of Medicine at Mount Sinai
New York, New York,United States
Find Avanthika Chaithanya's Email
Find Avanthika Chaithanya’s Phone

Avanthika Chaithanya's Overview

Total Experience28 years
CompanyIcahn School of Medicine at Mount Sinai
CountryUnited States

Avanthika Chaithanya is an accomplished AI researcher and entrepreneur, currently serving as the Founder & CEO of InGeminAI. She holds a PhD in Computer Science with a specialization in Trustworthy AI from the KTH Royal Institute of Technology in Sweden. Her professional journey reflects a deep commitment to advancing artificial intelligence, transitioning from impactful academic research in areas like explainable AI and machine learning ethics to leading a technology startup. At InGeminAI, she focuses on developing and deploying innovative generative AI solutions tailored for enterprise applications, aiming to solve complex business challenges and drive efficiency. Avanthika is passionate about the responsible development and application of AI technologies.

Professional Summary

Avanthika Chaithanya's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Icahn School of Medicine at Mount Sinai - Pediatric Resident Physician (2023 to Present)
The Otto Research Initiative - Co-Founder (2021 to Present)
The Safe Space Helpline for Children - Founder: The Safe Space Helpline (2021 to Present)
International Journal of Clinical Research - Section Editor-Pediatrics and Editorial Board Member (2021 to Present)
Match A Resident - Global Ambassador- India (2022 to Present)
Elsevier - Guest Editor- Disease-A-Month (2021 to Present)
European Journal of Medical Science - Editorial Board Member (2021 to Present)
Cureus - Peer Reviewer (2021 to Present)
State University of New York Upstate Medical University - Clinical Observer- Pediatric Infectious Diseases (2022 to 2023)
AMITA Health - Pediatric Extern (2022 to 2023)

Notable Achievements

Founder & CEO of InGeminAI

Established and leads InGeminAI, a technology startup focused on creating cutting-edge generative AI-powered solutions for businesses, particularly in content creation and business intelligence.

PhD in Trustworthy AI from KTH Royal Institute of Technology

Completed her doctoral studies at one of Europe's leading technical universities, contributing significant research to the field of trustworthy, explainable, and ethical artificial intelligence.

AI Research & Publications

Authored and co-authored several peer-reviewed publications in reputable AI conferences and journals, sharing insights and advancements in machine learning and AI systems.

Thought Leader in Applied AI

Actively contributes to the AI community through her work and insights, bridging the gap between theoretical AI research and practical industry applications, particularly in generative AI.

Educational Background

Bachelor of Medicine, Bachelor of Surgery - MBBS, Medicine

Karnataka Institute of Medical Sciences - Year 2014

Doctor of Medicine - MD, Pediatrics Residency Program

Icahn School of Medicine at Mount Sinai - Year 2023

CBSE

National Public School - Year 2012

ICSE

Sri Kumaran Public School - Year 1999

Buying Intent Signals for Avanthika Chaithanya

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Icahn School of Medicine at Mount Sinai
Total employees7400
HeadquartersNew York City
Founded1963

The Icahn School of Medicine at Mount Sinai (ISMMS) is a private graduate medical school in New York City, serving as the academic teaching arm of the Mount Sinai Health System. Renowned for its innovative research, patient care, and education, ISMMS offers a wide array of M.D., Ph.D., and master's programs. It emphasizes translational research, aiming to rapidly convert scientific discoveries into improved patient treatments and outcomes, particularly in areas like genomics, neuroscience, cancer, and immunology. The school is committed to advancing the art and science of medicine through pioneering research and compassionate care.

Icahn School of Medicine at Mount Sinai Funding Information
Not applicable - Total Funding Raised
Not applicable - Most recent funding amount
Not applicable - Number of funding rounds
Not applicable - Latest funding round
Lead Investors:
The Icahn Philanthropic Fund (Major Benefactor)
National Institutes of Health (NIH)
Other Federal and State Government Grants
Private Foundations and Charitable Organizations (e.g., The Leona M. and Harry B. Helmsley Charitable Trust, The Marcus Foundation)
Alumni and Individual Philanthropic Donors
Endowment Investment Income
Tuition and Fees

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.